The effect of transport-blocking drugs on secretion of fluid and electrolytes by the mandibular gland of red kangaroos, Macropus rufus

Arch Oral Biol. 1997 Oct-Nov;42(10-11):705-16. doi: 10.1016/s0003-9969(97)00074-5.

Abstract

Mechanisms of primary fluid formation by macropodine mandibular glands were investigated in anaesthetized red kangaroos using ion-transport and carbonic anhydrase inhibitors. Bumetanide at carotid plasma concentrations of 0.005-0.1 mmol/l progressively reduced a stable, acetylcholine-evoked flow rate of 1.02 +/- 0.024 ml/min to 0.16 +/- 0.016 ml/min (mean +/- SEM). Concurrently, saliva [Na], [Cl] and osmolality decreased, [K] and [HCO3] increased and HCO3 excretion was unaffected. High-rate cholinergic stimulation was unable to increase salivary flow above 12 +/- 1.5% of that for equivalent pre-bumetanide stimulation. Furosemide (1.0 mmol/l) and ethacrynate (0.5 mmol/l) caused depression of salivary flow and qualitatively similar effects on ion concentrations to those of bumetanide. Amiloride (up to 0.5 mmol/l) caused no reduction in salivary flow rates or [Na] but decreased [K] and [Cl] and increased [HCO3]. When compared with bumetanide alone, amiloride combined with bumetanide further augmented [K] and [HCO3] and lowered [Cl], but had no additional effects on Na or flow. At the higher level, 4-acetamido-4'- isothiocyanatostilbene-2,2'disulphonic acid (SITS) (0.05 and 0.5 mmol/l) stimulated fluid output, increased [HCO3] and [protein], and depressed [Na], [K] and [Cl]. Relative to bumetanide alone, SITS given with bumetanide had no additional effects on salivary flow or electrolytes. Methazolamide (0.5 mmol/l) in combination with bumetanide curtailed the decrease in [Cl] and the increases in [K] and [HCO3] associated with bumetanide. The residual methazolamide-resistant HCO3 excretion was sufficient to support 2-6% of primary fluid secretion. It was concluded that secretion of primary fluid by the kangaroo mandibular gland is initiated mainly (> 90%) by Cl transport resulting from Na-K-2Cl symport activity. A small proportion of the fluid secretion (up to 6%) appears to be supported by HCO3 secretion. No evidence was found for fluid secretion being dependent on Cl transport involving Na/H and Cl/HCO3 antiports or on HCO3 synthesis involving carbonic anhydrase.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / pharmacology
  • Acetylcholine / pharmacology
  • Amiloride / pharmacology
  • Animals
  • Biological Transport, Active / drug effects
  • Bumetanide / blood
  • Bumetanide / pharmacology
  • Carbonates / analysis
  • Carbonic Anhydrase Inhibitors / pharmacology
  • Chlorine / analysis
  • Cholinergic Agents / pharmacology
  • Diuretics / blood
  • Diuretics / pharmacology
  • Electrolytes / analysis*
  • Ethacrynic Acid / pharmacology
  • Furosemide / pharmacology
  • Ion Transport / drug effects
  • Macropodidae
  • Methazolamide / pharmacology
  • Osmolar Concentration
  • Potassium / analysis
  • Saliva / chemistry
  • Saliva / drug effects*
  • Saliva / metabolism
  • Salivary Glands / drug effects*
  • Salivary Glands / metabolism
  • Salivary Proteins and Peptides / analysis
  • Salivary Proteins and Peptides / drug effects
  • Salivary Proteins and Peptides / metabolism
  • Secretory Rate / drug effects
  • Sodium / analysis

Substances

  • Carbonates
  • Carbonic Anhydrase Inhibitors
  • Cholinergic Agents
  • Diuretics
  • Electrolytes
  • Salivary Proteins and Peptides
  • Bumetanide
  • 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
  • Chlorine
  • Amiloride
  • Furosemide
  • Sodium
  • Ethacrynic Acid
  • Acetylcholine
  • Potassium
  • Methazolamide